EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Application of the Mass Spectrometry–High‐Throughput Technique Over the Immunohistochemical Analysis for Human Brain Tumor Diagnosis and Prognosis: Insights Into Biomarkers' Identification for the Case Study of Grade IV Astrocytomas and Meningiomas

Kaouthar Louati iD, Fatma Kolsi, Manel Mellouli, Hanen Louati, Rim Kallel, Rania Zribi iD, Mahdi Borni, Leila Sellami Hakim, Amina Maalej, Sirine Choura, Mohamed Chamkha, Sami Sayadi und 5 weitere

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Kaouthar Louati und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Laboratory of Chemical, Galenic and Pharmacological Drug Development, University of Monastir, Monastir, Tunisia. Hauptthemen laut MEDLINE: Meningioma, Astrocytoma, Biomarkers, Tumor, Brain Neoplasms. Die Arbeit nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Higher Education, Ministry of Health, British Columbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human brain tumors were commonly monitored in hospital/clinical laboratories by immunohistochemistry (IHC) technique, which provides major insights into their classification. However, this technique remains laborious and still shows pitfalls. Therefore, the current study was endeavored to reveal the assets of the application of high‐throughput mass spectrometry (MS) for medical diagnosis. In this study, we focused on the Grade IV astrocytoma and meningioma brain tumors. The collected specimens were first monitored for histopathological diagnosis, followed by IHC staining for the characterization of stemness gene marker, then analyzed by a shotgun proteomic–based approach with high‐resolution tandem MS. The IHC analysis only confirmed the histopathological diagnosis, whereas the proteomic analysis unraveled several differently expressed proteins. By bioinformatics, the major enriched pathways and the significance of each protein with its meaningful relationships were identified. The key hub genes were allied for prognostic biomarkers of malignant, metastatic, and invasive forms of cancer with poor prognosis. Overall, the high‐throughput MS technique is the most powerful tool to achieve medical analysis at high sensitivity and accuracy and in a very straightforward and timely manner. Hence, its medical implementation in the hospital management system is imperative to counteract the caveats of traditional diagnostic methods and improve the quality of healthcare performance and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeningiomaAstrocytomaBiomarkers, TumorBrain NeoplasmsHigh-Throughput Screening AssaysMeningeal NeoplasmsHumansImmunohistochemistryPrognosisProteomicsMaleFemaleMiddle AgedTandem Mass SpectrometryAdult

Stichwörter der Autor:innen

biomarkersbrain tumorsimmunohistochemistrymass spectrometryproteomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Faculty of Pharmacy, Laboratory of Chemical, Galenic and Pharmacological Drug Development, University of Monastir, Monastir, Tunisia.
  • Department of Neurosurgery, Habib Bourguiba University Hospital, Sfax, Tunisia.
  • Faculty of Medicine, University of Sfax, Sfax, Tunisia.
  • Laboratory of Pathological Anatomy and Cytology, Habib Bourguiba University Hospital, Sfax, Tunisia.
  • College of Administrative and Financial Sciences, Saudi Electronic University, Riyadh, Saudi Arabia.
  • Faculty of Letters and Humanities, University of Sfax, Sfax, Tunisia.

ORCID-Profile: Kaouthar Louati, Rania Zribi

Förderung

  • Ministry of Higher Education
  • Ministry of Health, British Columbia

Zitieren

APA

Louati, K., Kolsi, F., Mellouli, M., Louati, H., Kallel, R., Zribi, R., Borni, M., Hakim, L. S., Maalej, A., Choura, S., Chamkha, M., Sayadi, S., Khemakhem, Z., Boudawara, T. S., Boudawara, M. Z., Zribi, K., & Safta, F. (2025). Application of the Mass Spectrometry–High‐Throughput Technique Over the Immunohistochemical Analysis for Human Brain Tumor Diagnosis and Prognosis: Insights Into Biomarkers' Identification for the Case Study of Grade IV Astrocytomas and Meningiomas. Biomedical Chromatography. https://doi.org/10.1002/bmc.70170

Vancouver

Louati K, Kolsi F, Mellouli M, Louati H, Kallel R, Zribi R, et al. Application of the Mass Spectrometry–High‐Throughput Technique Over the Immunohistochemical Analysis for Human Brain Tumor Diagnosis and Prognosis: Insights Into Biomarkers' Identification for the Case Study of Grade IV Astrocytomas and Meningiomas. Biomedical Chromatography. 2025. doi:10.1002/bmc.70170

BibTeX
@article{Louati2025,
  author = {Louati, Kaouthar and Kolsi, Fatma and Mellouli, Manel and Louati, Hanen and Kallel, Rim and Zribi, Rania and Borni, Mahdi and Hakim, Leila Sellami and Maalej, Amina and Choura, Sirine and Chamkha, Mohamed and Sayadi, Sami and Khemakhem, Zouheir and Boudawara, Tahya Sellami and Boudawara, Mohamed Zaher and Zribi, Kaouthar and Safta, Fathi},
  title = {Application of the Mass Spectrometry–High‐Throughput Technique Over the Immunohistochemical Analysis for Human Brain Tumor Diagnosis and Prognosis: Insights Into Biomarkers' Identification for the Case Study of Grade IV Astrocytomas and Meningiomas},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70170}
}
Kostenlos starten →